WEE1 and hepatocellular carcinoma: However, a Phase II trial using a Wee1 kinase inhibitor for the treatment of advanced solid cancers is currently underway [29], [30]; thus, the use of this type of inhibitor may be a realistic therapeutic option against advanced HCC.